Neuberger Berman Group LLC lessened its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,082,473 shares of the healthcare conglomerate’s stock after selling 26,372 shares during the period. Neuberger Berman Group LLC owned about 0.11% of UnitedHealth Group worth $212,002,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. raised its position in UnitedHealth Group by 1.2% during the 2nd quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after buying an additional 796,654 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. FMR LLC grew its stake in shares of UnitedHealth Group by 2.1% during the 2nd quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after purchasing an additional 1,168,324 shares during the period. Alliancebernstein L.P. grew its stake in UnitedHealth Group by 2.3% in the 2nd quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock valued at $1,466,104,000 after acquiring an additional 174,290 shares during the last quarter. Finally, TIAA CREF Investment Management LLC grew its stake in UnitedHealth Group by 3.9% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock valued at $1,090,720,000 after acquiring an additional 223,524 shares during the last quarter. Institutional investors own 86.00% of the company’s stock.
A number of equities research analysts recently commented on UNH shares. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 27th. Evercore ISI restated an “outperform” rating and issued a $255.00 target price (up from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Wells Fargo & Co restated an “outperform” rating and issued a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price on the stock in a report on Saturday, January 20th. Finally, ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Two equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $243.22.
In related news, Director Kenneth Irwin Shine sold 198 shares of UnitedHealth Group stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the sale, the director now directly owns 1,790,567 shares in the company, valued at $434,302,025.85. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 53,396 shares of company stock worth $12,262,067. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Inc (NYSE:UNH) traded up $3.35 during trading on Friday, reaching $229.37. 3,602,311 shares of the company’s stock were exchanged, compared to its average volume of 4,245,338. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. The firm has a market capitalization of $221,130.00, a P/E ratio of 24.21, a PEG ratio of 1.33 and a beta of 0.70. UnitedHealth Group Inc has a 1 year low of $156.49 and a 1 year high of $250.79.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. The company had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period last year, the business posted $2.11 earnings per share. research analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.58%.
COPYRIGHT VIOLATION WARNING: This news story was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://ledgergazette.com/2018/02/16/unitedhealth-group-inc-unh-shares-sold-by-neuberger-berman-group-llc.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.